• Теги
    • избранные теги
    • Компании34
      • Показать ещё
      Страны / Регионы1
      Показатели1
      Разное7
      • Показать ещё
      Люди4
      Международные организации1
      Издания1
Medco Health
Выбор редакции
26 октября 2016, 16:17

Express Scripts (ESRX) Q3 Earnings in Line, Revenues Lag

Pharmacy benefit manager Express Scripts Holding Company (ESRX) posted third-quarter 2016 earnings per share (excluding special items) of $1.74, in line with the Zacks Consensus Estimate, increasing 20% from the year-ago period.

27 июля 2016, 18:19

Express Scripts (ESRX) Posts In-Line Earnings, Lags Revenues (Revised)

Pharmacy benefit manager Express Scripts Holding Company (ESRX) posted second-quarter 2016 earnings per share (excluding special items) of $1.57, in line with the Zacks Consensus Estimate.

26 июля 2016, 15:55

Express Scripts (ESRX) Tops Q2 Earnings, Lags Revenues

Pharmacy benefit manager Express Scripts Holding Company (ESRX) posted second-quarter 2016 earnings per share (excluding special items) of $1.57, in line with the Zacks Consensus Estimate.

16 января 2013, 15:19

Cramer's Lightning Round - I'm No Longer Fighting American Capital Agency (1/15/13)

By SA Editor Miriam Metzinger: Stocks discussed on the Lightning Round session of Jim Cramer's Mad Money TV Program, Tuesday January 15. Bullish Calls: American Capital Agency (AGNC): "I used to fight this tooth and nail, because the dividend was a red flag. I now believe it can handle this yield. The dividend might not always stay this high, but I would buy it." Prospect Capital (PSEC): "It's a mezzanine lender. I think the economy is stronger than people think. That is a good situation." Kelly Services (KELYA): "I think it is going to be more advantageous for companies to use Kelly than to actually hire people full-time." Express Scripts (ESRX), Medco Health Solutions (MHS), CVS Caremark (CVS): (when asked about the merger between ESRX and MHS) "My take is that it is okay to buy these, but there are other players that are even better. I like CVS Caremark." Bearish Calls: Complete Story »

Выбор редакции
03 января 2013, 18:59

Valeant Pharmaceuticals ([[VRX]] +0.4%) completes its executive management team by naming Laizer Kornwasser as EVP/Group Chairman with responsibility for the firm's Canadian operations, U.S. Neurology, and various other U.S. functions, including managed care and distribution. Kornwasser was a senior exec at Medco Health prior to its acquisition by Express Scripts. (Recent other Valeant appointments) (PR)

Valeant Pharmaceuticals (VRX +0.4%) completes its executive management team by naming Laizer Kornwasser as EVP/Group Chairman with responsibility for the firm's Canadian operations, U.S. Neurology, and various other U.S. functions, including managed care and distribution. Kornwasser was a senior exec at Medco Health prior to its acquisition by Express Scripts. (Recent other Valeant appointments) (PR) Post your comment!

Выбор редакции
07 ноября 2012, 09:21

Express Scripts - Medco Deal Creates A Headache For Shareholders

By Robert Broens:Shares of Express Scripts Holding Company (ESRX) fell 12.3% in Tuesday's trading session. The company which manages billions of prescriptions for millions of consumers on behalf of employers, health plans and unions, reported its third quarter results on Monday after the close. Third Quarter Results Express Scripts reported third quarter revenues of $27.0 billion, up 133.3% on the year. The spectacular growth is driven by the acquisition of Medco Health Solutions.The company reported gross profits of $2.13 billion, up 155% on the year. Gross margins increased by 60 basis points to 8.1%.Express reported a net income of $391.4 million, or $0.47 per diluted share. Net income was up 20.5% on the year, while earnings per share fell 28.8% on the year. The number of shares outstanding increased significantly after acquiring Medco.Adjusted earnings came in at $1.02 per diluted share, up from $0.79 per share last year. EarningsComplete Story »

Выбор редакции
08 августа 2012, 22:39

Government review time helped Express Scripts plan Medco integration

(Reuters) - Express Scripts Holding Co said on Wednesday that the lengthy anti-trust review for its $29 billion purchase of rival pharmacy benefit manager Medco Health Solutions actually helped...